ArticleEngineering biology2020

Gene modification strategies using AO-mediated exon skipping and CRISPR/Cas9 as potential therapies for Duchenne muscular dystrophy patients.

Marthe Helene Solberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.